Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/4/2010

rical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, uncertainties regarding our future operating results, the risk that our product candidates will not obtain the requisite regulatory approvals to commercialize or that the future sales of our product candidates may be less than expected, and the risk factors set forth in the Company's filings with the Securities and Exchange Commission, including the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2010. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law. Condensed Consolidated Statements of Operations

(unaudited)

(in thousands)   Three months Nine monthsEnded September 30, Ended September 30,   2010 2009 2010 2009   Collaboration revenue $ 4,881 $  —  $ 11,282 $
8212;  Expenses   Research and development 6,723 1,513 16,182 6,301   General and administrative 1,067 885 3,892 2,670   Restructuring expense 4,038 —  4,038 494  Total expenses 11,828 2,398 24,112 9,465 Other income (expense) 53 29 46 120 Loss for the period before taxes 6,894 2,369 12,784 9,345 Income tax expense (recovery) — 16 (3,000) 12 Net loss $ 6,894 $ 2,385 $ 9,784   $ 9,357

Condensed Conso
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering
2. OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
3. OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
4. OncoGenex Pharmaceuticals to Present at the 9th Annual BIO Investor Forum
5. TEVA AND ONCOGENEX ANNOUNCE INITIATION OF SECOND PHASE 3 TRIAL OF CUSTIRSEN IN MEN WITH METASTATIC PROSTATE CANCER
6. OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
7. OncoGenex Reports Second Quarter Financial Results
8. OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
9. OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference
10. OncoGenex Reports First Quarter Financial Results
11. OncoGenex Pharmaceuticals to Webcast Discussion of Financial Results for Fourth Quarter and Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to a ... Market” the global orthobiologics market was valued at USD 3,754.6 ... worth USD 5,519.9million in 2019at a CAGR of 5.9% from ... 50 years and above is afflicted by bone and joint ... the year 2020. This has and will continue to increase ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Due to a ... last week, the Adult Stem Cell Technology Center, LLC ( ... support stem cell therapy research that might benefit ALS patients. ... cells for new stem cell technologies and therapeutic applications, FRC ... Ice Bucket Challenge donors who wish not to support ...
(Date:8/28/2014)... August 28, 2014 Best Sanitizers, Inc., ... an alcohol-based hand sanitizer, asks food processors and food ... the hand sanitizer they’re currently using to Best Sanitizers’ ... hygiene is critical to fighting cross-contamination and the spread ... Sanitizers believes there are key criteria that make a ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 The ability ... a culture that will allow individuals to perform at ... increasingly important for employers looking to compete in this ... are embracing this trend, as the sector increasingly focuses ... a company, which will have real results on the ...
Breaking Biology Technology:Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3
... and she's telling anyone within ear shot that Wisconsin has ... , , Molly Jahn The new dean of ... at the University of Wisconsin-Madison , Jahn believes Wisconsin ... one - biofuels. , ,She's well aware of criticism that ...
... to surge as Musicnotes, Inc. , a Madison company ... increased 45 percent in 2006 to more than $5.5 million. ... profit in 2006, said it sold sold almost 850,000 downloads ... has started strong in 2007. Year-to-date sales are up nearly ...
... that operate in the clean technology industry are becoming more ... the opportunity to impress the 600 investors that are expected ... in San Francisco. , , Orion Energy Systems of ... 20 emerging clean technology companies that will present company overviews ...
Cached Biology Technology:UW-Madison dean predicts bio-economy will fuel Wisconsin 2UW-Madison dean predicts bio-economy will fuel Wisconsin 3
(Date:8/28/2014)... delivering compounds that could positively impact the ... be possible, thanks to researchers in Penn ... vaginal suppository made from the seaweed-derived food ... drug Tenofovir provides a woman-initiated, drug-delivery vehicle ... sexually transmitted infections during unprotected heterosexual intercourse, ...
(Date:8/28/2014)... good examples of complex systems. Their infrastructure equipment ... for cooling, transport to supply fuel, and ICT ... the network chain is interconnected with a wider ... team of UK-based scientists has studied various aspects ... have been published in EPJ B by Gaihua ...
(Date:8/28/2014)... Philadelphia, PA, August 28, 2014 Dyslexia, the ... States, is a neurological reading disability that occurs ... written language don,t function normally. , The use ... how brain activity is disrupted in dyslexia. However, ... small number of brain regions, leaving a gap ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Inter-dependent networks stress test 2Dyslexic readers have disrupted network connections in the brain 2
... New York / Heidelberg, 5 April 2011 Springer ... Sciences (JESS), the official publication of the Association ... spring 2011, the journal will be available in print ... The Journal of Environmental Studies and Sciences ...
... in Spanish . Burgers, meat loaf and ... meat that,s left over after steaks and roasts have been carved ... to ensure that imported beef trim is safe to eat has ... scientists who conducted the research and colleagues from Uruguay, which exports ...
... Loss of glaciers and snowpack due to climate warming ... insect, the meltwater stonefly, according to a study recently released ... study, scientists with the U.S. Geological Survey, the University of ... illustrate that alpine aquatic insects can be good early warning ...
Cached Biology News:Food safety study of beef 'trim' leads to ongoing research collaboration 2
Buckets for 2 racks of 5 tubes, type Stago/Hitachi...
... Thermal Cycler (MBS) is a ... medium to high throughput PCR. ... latest in satellite block technology, ... control, resulting in a system ...
... The AccuSpot automates LC microfractionaction, spotting ... With the AccuSpot system, LC eluent can ... plates, in trace amounts (eg.50nl). Matrix solutions ... automatic preparation of target plated for MALDI-TOF-MS ...
CQCS kit for etra KR 4i , (other units)....
Biology Products: